rs35732034

Positions:

chr2-162268086-C-T

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 8P and 9B. PVS1BP6BS1BS2

The NM_022168.4(IFIH1):c.2807+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00853 in 1,591,006 control chromosomes in the GnomAD database, including 86 homozygotes. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0054 ( 7 hom., cov: 33)

Exomes 𝑓: 0.0089 ( 79 hom. )

Consequence

IFIH1
NM_022168.4 splice_donor

Scores

Splicing: ADA: 1.000

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2B:7

Conservation

PhyloP100: 7.28

Variant links:

Genes affected

IFIH1 (HGNC:18873): (interferon induced with helicase C domain 1) IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]

IFIH1 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PVS1

Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.

BP6

Variant 2-162268086-C-T is Benign according to our data. Variant chr2-162268086-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 541779.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Benign=2, Pathogenic=1}. Variant chr2-162268086-C-T is described in Lovd as [Benign]. Variant chr2-162268086-C-T is described in Lovd as [Pathogenic].

BS1

Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.00886 (12746/1438704) while in subpopulation EAS AF= 0.0206 (807/39234). AF 95% confidence interval is 0.0194. There are 79 homozygotes in gnomad4_exome. There are 6454 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.

BS2

High Homozygotes in GnomAd4 at 7 AD,AR gene

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
IFIH1	NM_022168.4 linkuse as main transcript	c.2807+1G>A		splice_donor_variant		ENST00000649979.2	NP_071451.2
IFIH1	XM_047445407.1 linkuse as main transcript	c.2090+1G>A		splice_donor_variant			XP_047301363.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
IFIH1	ENST00000649979.2 linkuse as main transcript	c.2807+1G>A		splice_donor_variant			NM_022168.4	ENSP00000497271	P1	Q9BYX4-1

Frequencies

GnomAD3 genomes

AF:

0.00538

AC:

818

AN:

152184

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00152

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00353

Gnomad ASJ

AF:

0.00835

Gnomad EAS

AF:

0.00790

Gnomad SAS

AF:

0.0101

Gnomad FIN

AF:

0.00179

Gnomad MID

AF:

0.00633

Gnomad NFE

AF:

0.00803

Gnomad OTH

AF:

0.00719

GnomAD3 exomes

AF:

0.00658

AC:

1559

AN:

236838

Hom.:

AF XY:

0.00718

AC XY:

919

AN XY:

127994

show subpopulations

Gnomad AFR exome

AF:

0.00139

Gnomad AMR exome

AF:

0.00307

Gnomad ASJ exome

AF:

0.0111

Gnomad EAS exome

AF:

0.00221

Gnomad SAS exome

AF:

0.0118

Gnomad FIN exome

AF:

0.00136

Gnomad NFE exome

AF:

0.00836

Gnomad OTH exome

AF:

0.00701

GnomAD4 exome

AF:

0.00886

AC:

12746

AN:

1438704

Hom.:

Cov.:

AF XY:

0.00904

AC XY:

6454

AN XY:

714000

show subpopulations

Gnomad4 AFR exome

AF:

0.00126

Gnomad4 AMR exome

AF:

0.00311

Gnomad4 ASJ exome

AF:

0.0105

Gnomad4 EAS exome

AF:

0.0206

Gnomad4 SAS exome

AF:

0.0118

Gnomad4 FIN exome

AF:

0.00202

Gnomad4 NFE exome

AF:

0.00901

Gnomad4 OTH exome

AF:

0.00794

GnomAD4 genome

AF:

0.00539

AC:

821

AN:

152302

Hom.:

Cov.:

AF XY:

0.00487

AC XY:

363

AN XY:

74470

show subpopulations

Gnomad4 AFR

AF:

0.00152

Gnomad4 AMR

AF:

0.00353

Gnomad4 ASJ

AF:

0.00835

Gnomad4 EAS

AF:

0.00792

Gnomad4 SAS

AF:

0.0101

Gnomad4 FIN

AF:

0.00179

Gnomad4 NFE

AF:

0.00803

Gnomad4 OTH

AF:

0.00854

Alfa

AF:

0.00780

Hom.:

Bravo

AF:

0.00493

TwinsUK

AF:

0.00998

AC:

ALSPAC

AF:

0.0104

AC:

ESP6500AA

AF:

0.00113

AC:

ESP6500EA

AF:

0.00756

AC:

ExAC

AF:

0.00682

AC:

828

Asia WGS

AF:

0.00895

AC:

AN:

3478

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:2Benign:7

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

not provided

Pathogenic:1Benign:3

Likely benign, criteria provided, single submitter	clinical testing	GeneDx	May 05, 2021	This variant is associated with the following publications: (PMID: 23856252, 22344438, 19264985, 28716935) -
Pathogenic, criteria provided, single submitter	clinical testing	Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital	Dec 17, 2022	- -
Likely benign, criteria provided, single submitter	not provided	Breakthrough Genomics, Breakthrough Genomics	-	- -
Benign, criteria provided, single submitter	clinical testing	CeGaT Center for Human Genetics Tuebingen	Jul 01, 2024	IFIH1: BS1, BS2 -

Immunodeficiency 95

Pathogenic:1

Pathogenic, no assertion criteria provided

literature only

OMIM

Jun 15, 2022

- -

Aicardi-Goutieres syndrome 7

Benign:1

Likely benign, criteria provided, single submitter

clinical testing

Genetics and Molecular Pathology, SA Pathology

Jun 30, 2020

- -

Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1;C5676929:Immunodeficiency 95

Benign:1

Likely benign, criteria provided, single submitter

clinical testing

Fulgent Genetics, Fulgent Genetics

Apr 25, 2022

- -

Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1

Benign:1

Benign, criteria provided, single submitter

clinical testing

Labcorp Genetics (formerly Invitae), Labcorp

Feb 01, 2024

- -

IFIH1-related disorder

Benign:1

Benign, no assertion criteria provided

clinical testing

PreventionGenetics, part of Exact Sciences

Mar 13, 2019

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_addAF

Uncertain

0.12

BayesDel_noAF

Pathogenic

0.41

CADD

Pathogenic

DANN

Uncertain

1.0

Eigen

Pathogenic

1.1

Eigen_PC

Pathogenic

0.95

FATHMM_MKL

Pathogenic

1.0

MutationTaster

Benign

1.0

D;D

GERP RS

4.7

Splicing

Name

Calibrated prediction

Score

Prediction

dbscSNV1_ADA

Pathogenic

1.0

dbscSNV1_RF

Pathogenic

0.94

SpliceAI score (max)

0.98

Details are displayed if max score is > 0.2

DS_DL_spliceai

0.98

Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over